search
Back to results

Multimodal Therapeutic Approach in Undernourished Maintenance Hemodialysis Patients (AMERICANO) (AMERICANO)

Primary Purpose

Chronic Kidney Failure

Status
Unknown status
Phase
Phase 3
Locations
France
Study Type
Interventional
Intervention
training on ergonomic bicycle
Testosterone
Oral nutritional supplementation
n3 polyunsaturated fatty acid
Sponsored by
University Hospital, Clermont-Ferrand
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Chronic Kidney Failure focused on measuring Physical exercises, Oral nutritional supplementation, Multimodal, Hemodialysis, Protein-Energy Wasting

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Hemodialysis patient since at least 6 month
  • Patient aged 18 years or older
  • Written consent to participate in the study
  • No acute infection or hospitalization
  • Opinion of Cardiologist saying there is no known evidence against the evaluation of the maximum exercise capacity
  • Protein-energy wasting diagnosed if at least two of this characteristics are present
  • Serum albumin <3.8 g per 100 ml (Bromcresol Green)
  • Serum prealbumin (transthyretin) <30mg per 100 ml
  • Reduce body mass (BMI <23)
  • Unintentional 10% weight loss over 6 months
  • Lean body mass index < 10th percentile

Exclusion Criteria:

  • Presence of comorbidity which compromising the survival within 6 month
  • Unintentional low DEI <20 kcal kg_1 day_1
  • HIV or HCV positive
  • History of hormone dependent cancer
  • Suspected or confirmed prostate cancer or breast carcinoma
  • Known hypersensitivity for testosterone
  • Presence or history of hepatic tumor
  • Inability to follow the rehabilitation program
  • Inadequate dialysis dosage (<12 hours / week or Kt/V index< 1,2) Pregnant or planning pregnancy and lactating women during study period
  • Adult patient protected by law
  • Patient who don't sign his informed consent

Sites / Locations

  • CHU Clermont-FerrandRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Other

Arm Label

treated group

control group

Arm Description

testosteron, oral nutritional supplementation, n3 polyunsaturated fatty acid, training on ergonomic bicycle

oral nutritional supplementation

Outcomes

Primary Outcome Measures

Change of physical endurance on bicycle
Physical endurance on bicycle at intermediate power between maximal power and ventilatory threshold power (Pmax+Pthreshold)/2

Secondary Outcome Measures

Transthyrin serum concentration evolution
(Unit of Measure: g/L)
Health-related quality of life assessment using SF-36 scale and KDQOL
Karnofsky score
Maximal power on bicycle
Unit of Measure: Watt
Nutritional parameters
weight (Kg)
serum levels of albumin (g/L)
determination of urea (mmol/L)
determination of creatinine(µmol/L)
Body composition
(evaluated by bioimpedance)

Full Information

First Posted
April 3, 2015
Last Updated
July 28, 2016
Sponsor
University Hospital, Clermont-Ferrand
Collaborators
Human Nutrition Research Center Rhône-Alpes, Société Francophone Nutrition Clinique et Métabolisme, Nutricia, Inc.
search

1. Study Identification

Unique Protocol Identification Number
NCT02418065
Brief Title
Multimodal Therapeutic Approach in Undernourished Maintenance Hemodialysis Patients (AMERICANO)
Acronym
AMERICANO
Official Title
Multimodal Therapeutic Approach by Exercise, Oral Nutritional Supplementation, Omega 3 and Androgen in Undernourished Maintenance Hemodialysis Patients (AMERICANO)
Study Type
Interventional

2. Study Status

Record Verification Date
July 2016
Overall Recruitment Status
Unknown status
Study Start Date
December 2013 (undefined)
Primary Completion Date
March 2017 (Anticipated)
Study Completion Date
April 2017 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University Hospital, Clermont-Ferrand
Collaborators
Human Nutrition Research Center Rhône-Alpes, Société Francophone Nutrition Clinique et Métabolisme, Nutricia, Inc.

4. Oversight

5. Study Description

Brief Summary
The aim of the study is to evaluate a 3 months integrated multimodal therapeutic approach including exercise training program with ergocycle during dialysis sessions, oral nutritional supplementation, omega 3 and androgen, on effort tolerance and quality of life of under-nourish maintenance hemodialysis Chronic Kidney Disease (CKD) patient.
Detailed Description
The aim of the study is to evaluate a 3 months integrated multimodal therapeutic approach including exercise training program with ergocycle during dialysis sessions, oral nutritional supplementation, omega 3 and androgen, on effort tolerance and quality of life of under-nourish maintenance hemodialysis Chronic Kidney Disease (CKD) patient.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Chronic Kidney Failure
Keywords
Physical exercises, Oral nutritional supplementation, Multimodal, Hemodialysis, Protein-Energy Wasting

7. Study Design

Primary Purpose
Prevention
Study Phase
Phase 3
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
120 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
treated group
Arm Type
Experimental
Arm Description
testosteron, oral nutritional supplementation, n3 polyunsaturated fatty acid, training on ergonomic bicycle
Arm Title
control group
Arm Type
Other
Arm Description
oral nutritional supplementation
Intervention Type
Other
Intervention Name(s)
training on ergonomic bicycle
Intervention Type
Drug
Intervention Name(s)
Testosterone
Intervention Type
Drug
Intervention Name(s)
Oral nutritional supplementation
Intervention Type
Drug
Intervention Name(s)
n3 polyunsaturated fatty acid
Primary Outcome Measure Information:
Title
Change of physical endurance on bicycle
Description
Physical endurance on bicycle at intermediate power between maximal power and ventilatory threshold power (Pmax+Pthreshold)/2
Time Frame
At months 3 and 15 after inclusion
Secondary Outcome Measure Information:
Title
Transthyrin serum concentration evolution
Description
(Unit of Measure: g/L)
Time Frame
at day 1
Title
Health-related quality of life assessment using SF-36 scale and KDQOL
Time Frame
at day 1
Title
Karnofsky score
Time Frame
at ady 1
Title
Maximal power on bicycle
Description
Unit of Measure: Watt
Time Frame
at day 1
Title
Nutritional parameters
Description
weight (Kg)
Time Frame
at day 1
Title
serum levels of albumin (g/L)
Time Frame
at day 1
Title
determination of urea (mmol/L)
Time Frame
at day 1
Title
determination of creatinine(µmol/L)
Time Frame
at 1 year
Title
Body composition
Description
(evaluated by bioimpedance)
Time Frame
at day 1

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Hemodialysis patient since at least 6 month Patient aged 18 years or older Written consent to participate in the study No acute infection or hospitalization Opinion of Cardiologist saying there is no known evidence against the evaluation of the maximum exercise capacity Protein-energy wasting diagnosed if at least two of this characteristics are present Serum albumin <3.8 g per 100 ml (Bromcresol Green) Serum prealbumin (transthyretin) <30mg per 100 ml Reduce body mass (BMI <23) Unintentional 10% weight loss over 6 months Lean body mass index < 10th percentile Exclusion Criteria: Presence of comorbidity which compromising the survival within 6 month Unintentional low DEI <20 kcal kg_1 day_1 HIV or HCV positive History of hormone dependent cancer Suspected or confirmed prostate cancer or breast carcinoma Known hypersensitivity for testosterone Presence or history of hepatic tumor Inability to follow the rehabilitation program Inadequate dialysis dosage (<12 hours / week or Kt/V index< 1,2) Pregnant or planning pregnancy and lactating women during study period Adult patient protected by law Patient who don't sign his informed consent
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Patrick LACARIN
Phone
04 73 75 11 95
Email
placarin@chu-clermontferrand.fr
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Noël CANO
Organizational Affiliation
University Hospital, Clermont-Ferrand
Official's Role
Principal Investigator
Facility Information:
Facility Name
CHU Clermont-Ferrand
City
Clermont-Ferrand
ZIP/Postal Code
63003
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Patrick LACARIN
Phone
04 73 75 11 95
Email
placarin@chu-clermontferrand.fr
First Name & Middle Initial & Last Name & Degree
Dorothée BAZIN KARA
First Name & Middle Initial & Last Name & Degree
Didier DUCLOUX
First Name & Middle Initial & Last Name & Degree
Anne-Elizabeth HENG
First Name & Middle Initial & Last Name & Degree
Fitsum GUEBREEGZIABHE
First Name & Middle Initial & Last Name & Degree
Denis FOUQUE
First Name & Middle Initial & Last Name & Degree
Christophe MARIAT
First Name & Middle Initial & Last Name & Degree
Atman HADDJELMRABET
First Name & Middle Initial & Last Name & Degree
Didier AGUILERA
First Name & Middle Initial & Last Name & Degree
Eric LARUELLE
First Name & Middle Initial & Last Name & Degree
Charles CHAZOT
First Name & Middle Initial & Last Name & Degree
Abdallah GUERRAOUI
First Name & Middle Initial & Last Name & Degree
Myriam ISNARD
First Name & Middle Initial & Last Name & Degree
Prisca MUTINELLI
First Name & Middle Initial & Last Name & Degree
Hélène DE PRENEUF
First Name & Middle Initial & Last Name & Degree
François MAURICE
First Name & Middle Initial & Last Name & Degree
Pedro PALACIN
First Name & Middle Initial & Last Name & Degree
Daniel TETA
First Name & Middle Initial & Last Name & Degree
Marie ESSIG

12. IPD Sharing Statement

Citations:
PubMed Identifier
32390133
Citation
Mah JY, Choy SW, Roberts MA, Desai AM, Corken M, Gwini SM, McMahon LP. Oral protein-based supplements versus placebo or no treatment for people with chronic kidney disease requiring dialysis. Cochrane Database Syst Rev. 2020 May 11;5(5):CD012616. doi: 10.1002/14651858.CD012616.pub2.
Results Reference
derived

Learn more about this trial

Multimodal Therapeutic Approach in Undernourished Maintenance Hemodialysis Patients (AMERICANO)

We'll reach out to this number within 24 hrs